Pharma Veterans

Dear Colleagues!  Today is Pharma Veterans Blog Post #167. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from previous…… Phase II. Introduction of Generics of New Chemical Entities (NCEs) Come 1990s, the Local Pharma got into manufacturing and marketing of newer molecules. They particularly targeted high-priced products. For example, Losec (omeprazole) was becoming popular and became a favorite molecule for bringing generics. There were many more like this. These generics offered some relief in price, 15-25%. They were not cheap, but the doctors did not fully believe that these would give

Dear Colleagues!  Today is Pharma Veterans Blog Post #166. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from previous…… When I started working in Pharma in 1975, MNCs were supreme. They had the products, the knowledge, the resources, the prestige and eventually, the business. I remember we had some target, but we never worried about it, for two reasons. One, the targets were small, and the growth expectation used to be modest; two, the targets were achieved without any fuss. In 1975, the generic scheme introduced by the then Health Minister late Sheikh Rasheed, was the subject of universal c